Q-Line Biotech SME IPO Review
Q-Line Biotech SME IPO is yet to receive analyst coverage — analyst reports and verdicts will be updated here as and when they are published. The IPO is priced in the band of ₹326-343 per share with a minimum lot size of 400 shares (minimum investment of ₹137,200) . Subscription opens on 21 May 2026 and closes on 25 May 2026. In the meantime, you can track the live GMP and subscription status for early market signals.
Table of Contents
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Q-Line Biotech SME IPO?
Analyst coverage for Q-Line Biotech SME IPO has not been published yet. Analyst verdicts will be updated here as they come in — check back closer to the subscription dates.
What does the score of N/A mean for Q-Line Biotech SME IPO?
Analyst scoring is not yet available for Q-Line Biotech SME IPO. The score will be updated once analyst reports start coming in.
What are the listing gain expectations for Q-Line Biotech SME IPO?
Grey market data is not yet available for Q-Line Biotech SME IPO. As the subscription period approaches, GMP signals typically start forming. Check the GMP page for the latest updates.
What is the price band and lot size of Q-Line Biotech SME IPO?
Q-Line Biotech SME IPO is priced at ₹326-343 per share. The minimum lot size is 400 shares, making the minimum investment approximately ₹137,200 at the upper end of the price band. The subscription window is open from 21 May 2026 to 25 May 2026.
Explore Q-Line Biotech SME IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!